D-Light Intervention (D-Light)

January 14, 2016 updated by: University of Ulster

D-Light Intervention: A Randomised Controlled Human Intervention Study to Assess the Impact of Vitamin D From Milk and Supplements on Functional Health Outcomes and Future Vitamin D Synthesis From UV Exposure

Vitamin D insufficiency has become a global concern, with low vitamin D status associated with bone disorders, cardiovascular disease and certain cancers. The United Kingdom (UK) and Ireland are at particular risk of vitamin D deficiency owing to the northerly latitude, increased use of sunscreen, decreased sun exposure and a high level of cloud cover. A recent survey in the UK showed that more than 50% of UK adults have insufficient vitamin D status, with lower levels noted in the winter months. Variations in vitamin D status have been known to vary between summer and winter, owing to our northern latitude (52-55°N) the Ultraviolet (UV)-B intensity in Northern Ireland is inadequate to promote the dermal synthesis of vitamin D during the winter months, causing us to rely on dietary sources. The aim of this intervention is to investigate the main effects of vitamin D3-fortified milk and supplemental vitamin D3 on vitamin D status and functional health outcomes during the winter, and how this intervention will affect subsequent dermal synthesis of vitamin D from UV exposure. Participants will be recruited from the local community. Blood samples will be collected from each participant at two timepoints (September/October and March/April). Pre- and post-intervention blood pressure, grip strength, height, weight, waist and hip circumferences will be measured, in addition participants will undergo a dual energy x-ray absorptiometry (DXA) scan to assess body composition and bone mineral density. Information on general health, lifestyle, physical activity, dietary intake and typical behaviours in the sun will be collected. Following the dietary intervention, a subset of participants will be invited to participate in a follow-up study, examining UV exposure during the summer months, when they will wear a personal wrist dosimeter for 1 month, complete a sun dairy and provide 2 additional blood samples.

Study Overview

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Coleraine, United Kingdom, BT52 1SA
        • Human Intervention Studies Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 20-40 years old
  • Apparently healthy
  • Living on the island of Ireland

Exclusion Criteria:

  • Below 20 years and aged 40 years or above
  • Not living on the island of Ireland
  • Pregnant or lactating women and those planning to become pregnant
  • Individuals who have been taking a vitamin D or calcium containing supplement in the previous three months
  • Those with food intolerances or allergies that would affect their ability to consume study milk
  • Individuals following a diet which excludes milk (e.g. vegans)
  • Those with a diagnosed chronic medical condition or on prescribed medication known to effect vitamin D metabolism
  • Those who are planning a sun holiday during the winter months (Oct-Mar)
  • Adults with learning, or any other difficulties that would prevent them from completing the study protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment 1
500ml fortified milk (10µg vitamin D3) +1 supplement capsule (10µg vitamin D3) daily for 24 weeks
Experimental: Treatment 2
500ml fortified milk (10µg vitamin D3) +1 supplement capsule (placebo) daily for 24 weeks
Experimental: Treatment 3
500ml unfortified milk (placebo) +1 supplement capsule (10µg vitamin D3) daily for 24 weeks
Placebo Comparator: Treatment 4
500ml unfortified milk (placebo) +1 supplement capsule (placebo) daily for 24 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in vitamin D status (25-hydroxyvitamin D serum concentration)
Time Frame: Baseline + post-intervention (24weeks)
Blood analysis
Baseline + post-intervention (24weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in body composition
Time Frame: Baseline + post-intervention (24weeks)
Assessed by dual energy X-ray absorptiometry (DXA)
Baseline + post-intervention (24weeks)
Change in muscle strength
Time Frame: Baseline + post-intervention (24weeks)
Assessed by grip strength
Baseline + post-intervention (24weeks)
Change in inflammation status
Time Frame: Baseline + post-intervention (24weeks)
Blood analysis
Baseline + post-intervention (24weeks)
Change in lipid profile
Time Frame: Baseline + post-intervention (24weeks)
Blood analysis
Baseline + post-intervention (24weeks)
Change in glucose levels
Time Frame: Baseline + post-intervention (24weeks)
Blood analysis
Baseline + post-intervention (24weeks)
Change in insulin concentrations
Time Frame: Baseline + post-intervention (24weeks)
Blood analysis
Baseline + post-intervention (24weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
UV exposure (follow-up)
Time Frame: 8 weeks post-intervention (32-40 weeks)
Assessed by UV wrist monitors
8 weeks post-intervention (32-40 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

May 11, 2015

First Submitted That Met QC Criteria

July 10, 2015

First Posted (Estimate)

July 13, 2015

Study Record Updates

Last Update Posted (Estimate)

January 15, 2016

Last Update Submitted That Met QC Criteria

January 14, 2016

Last Verified

January 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on 25-hydroxyvitamin D Concentration (Vitamin D Status)

Clinical Trials on Fortified milk (10µg vitamin D3)

3
Subscribe